nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—UGT1A1—Mycophenolic acid—systemic scleroderma	0.533	0.642	CbGbCtD
Dolutegravir—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.298	0.358	CbGbCtD
Dolutegravir—Hepatitis C—Mycophenolic acid—systemic scleroderma	0.00925	0.0546	CcSEcCtD
Dolutegravir—Autoimmune disorder—Leflunomide—systemic scleroderma	0.00504	0.0298	CcSEcCtD
Dolutegravir—Autoimmune disorder—Mycophenolic acid—systemic scleroderma	0.00481	0.0284	CcSEcCtD
Dolutegravir—Opportunistic infection—Leflunomide—systemic scleroderma	0.00418	0.0247	CcSEcCtD
Dolutegravir—Opportunistic infection—Mycophenolic acid—systemic scleroderma	0.00399	0.0235	CcSEcCtD
Dolutegravir—Opportunistic infection—Mycophenolate mofetil—systemic scleroderma	0.00315	0.0186	CcSEcCtD
Dolutegravir—Serum creatinine increased—Lisinopril—systemic scleroderma	0.00235	0.0139	CcSEcCtD
Dolutegravir—Opportunistic infection—Prednisone—systemic scleroderma	0.00213	0.0126	CcSEcCtD
Dolutegravir—Opportunistic infection—Methotrexate—systemic scleroderma	0.00178	0.0105	CcSEcCtD
Dolutegravir—Inflammation—Leflunomide—systemic scleroderma	0.00173	0.0102	CcSEcCtD
Dolutegravir—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.00162	0.00957	CcSEcCtD
Dolutegravir—Abnormal dreams—Mycophenolic acid—systemic scleroderma	0.00159	0.00937	CcSEcCtD
Dolutegravir—Rash maculo-papular—Leflunomide—systemic scleroderma	0.00153	0.00903	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Pentoxifylline—systemic scleroderma	0.00143	0.00841	CcSEcCtD
Dolutegravir—Hepatitis—Pentoxifylline—systemic scleroderma	0.00135	0.00799	CcSEcCtD
Dolutegravir—Renal impairment—Mycophenolic acid—systemic scleroderma	0.00122	0.00723	CcSEcCtD
Dolutegravir—Immune system disorder—Pentoxifylline—systemic scleroderma	0.00122	0.00721	CcSEcCtD
Dolutegravir—Neutropenia—Captopril—systemic scleroderma	0.0012	0.00707	CcSEcCtD
Dolutegravir—Flatulence—Pentoxifylline—systemic scleroderma	0.00116	0.00685	CcSEcCtD
Dolutegravir—Rash maculo-papular—Mycophenolate mofetil—systemic scleroderma	0.00115	0.0068	CcSEcCtD
Dolutegravir—Renal failure—Captopril—systemic scleroderma	0.00112	0.00663	CcSEcCtD
Dolutegravir—Renal impairment—Lisinopril—systemic scleroderma	0.0011	0.00651	CcSEcCtD
Dolutegravir—Blood creatinine increased—Mycophenolic acid—systemic scleroderma	0.00109	0.00645	CcSEcCtD
Dolutegravir—Abdominal discomfort—Azathioprine—systemic scleroderma	0.00107	0.00633	CcSEcCtD
Dolutegravir—Abdominal pain upper—Mycophenolic acid—systemic scleroderma	0.00106	0.00628	CcSEcCtD
Dolutegravir—Immune system disorder—Mometasone—systemic scleroderma	0.00105	0.00623	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Mycophenolic acid—systemic scleroderma	0.00103	0.00607	CcSEcCtD
Dolutegravir—Hepatitis—Captopril—systemic scleroderma	0.00103	0.00605	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.000996	0.00588	CcSEcCtD
Dolutegravir—Neutropenia—Leflunomide—systemic scleroderma	0.000987	0.00583	CcSEcCtD
Dolutegravir—Blood creatinine increased—Lisinopril—systemic scleroderma	0.000983	0.00581	CcSEcCtD
Dolutegravir—Renal impairment—Mycophenolate mofetil—systemic scleroderma	0.000966	0.0057	CcSEcCtD
Dolutegravir—Hyperglycaemia—Leflunomide—systemic scleroderma	0.000952	0.00562	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Azathioprine—systemic scleroderma	0.000943	0.00557	CcSEcCtD
Dolutegravir—Neutropenia—Mycophenolic acid—systemic scleroderma	0.000942	0.00556	CcSEcCtD
Dolutegravir—Skin disorder—Pentoxifylline—systemic scleroderma	0.000934	0.00551	CcSEcCtD
Dolutegravir—Renal failure—Leflunomide—systemic scleroderma	0.000925	0.00546	CcSEcCtD
Dolutegravir—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.000908	0.00536	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Leflunomide—systemic scleroderma	0.00089	0.00526	CcSEcCtD
Dolutegravir—Renal failure—Mycophenolic acid—systemic scleroderma	0.000883	0.00521	CcSEcCtD
Dolutegravir—Insomnia—Pentoxifylline—systemic scleroderma	0.000869	0.00513	CcSEcCtD
Dolutegravir—Blood creatinine increased—Mycophenolate mofetil—systemic scleroderma	0.000861	0.00509	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Mycophenolic acid—systemic scleroderma	0.000849	0.00501	CcSEcCtD
Dolutegravir—Neutropenia—Lisinopril—systemic scleroderma	0.000848	0.00501	CcSEcCtD
Dolutegravir—Hepatitis—Leflunomide—systemic scleroderma	0.000845	0.00499	CcSEcCtD
Dolutegravir—Urinary tract disorder—Leflunomide—systemic scleroderma	0.000834	0.00493	CcSEcCtD
Dolutegravir—Urethral disorder—Leflunomide—systemic scleroderma	0.000828	0.00489	CcSEcCtD
Dolutegravir—Hyperglycaemia—Lisinopril—systemic scleroderma	0.000818	0.00483	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.000811	0.00479	CcSEcCtD
Dolutegravir—Immune system disorder—Azathioprine—systemic scleroderma	0.000808	0.00477	CcSEcCtD
Dolutegravir—Hepatitis—Mycophenolic acid—systemic scleroderma	0.000806	0.00476	CcSEcCtD
Dolutegravir—Urinary tract disorder—Mycophenolic acid—systemic scleroderma	0.000796	0.0047	CcSEcCtD
Dolutegravir—Renal failure—Lisinopril—systemic scleroderma	0.000795	0.00469	CcSEcCtD
Dolutegravir—Urethral disorder—Mycophenolic acid—systemic scleroderma	0.00079	0.00467	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000786	0.00464	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.000765	0.00452	CcSEcCtD
Dolutegravir—Immune system disorder—Leflunomide—systemic scleroderma	0.000763	0.00451	CcSEcCtD
Dolutegravir—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00076	0.00449	CcSEcCtD
Dolutegravir—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.000743	0.00439	CcSEcCtD
Dolutegravir—Mental disorder—Leflunomide—systemic scleroderma	0.00074	0.00437	CcSEcCtD
Dolutegravir—Inflammation—Methotrexate—systemic scleroderma	0.00074	0.00437	CcSEcCtD
Dolutegravir—Hepatitis—Lisinopril—systemic scleroderma	0.000726	0.00429	CcSEcCtD
Dolutegravir—Flatulence—Leflunomide—systemic scleroderma	0.000725	0.00428	CcSEcCtD
Dolutegravir—Urinary tract disorder—Lisinopril—systemic scleroderma	0.000717	0.00423	CcSEcCtD
Dolutegravir—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000717	0.00423	CcSEcCtD
Dolutegravir—Fatigue—Mometasone—systemic scleroderma	0.000715	0.00422	CcSEcCtD
Dolutegravir—Urethral disorder—Lisinopril—systemic scleroderma	0.000712	0.0042	CcSEcCtD
Dolutegravir—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000708	0.00418	CcSEcCtD
Dolutegravir—Mental disorder—Mycophenolic acid—systemic scleroderma	0.000706	0.00417	CcSEcCtD
Dolutegravir—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000697	0.00411	CcSEcCtD
Dolutegravir—Flatulence—Mycophenolic acid—systemic scleroderma	0.000691	0.00408	CcSEcCtD
Dolutegravir—Asthenia—Pentoxifylline—systemic scleroderma	0.00069	0.00407	CcSEcCtD
Dolutegravir—Pruritus—Pentoxifylline—systemic scleroderma	0.00068	0.00401	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000678	0.004	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00067	0.00396	CcSEcCtD
Dolutegravir—Vertigo—Leflunomide—systemic scleroderma	0.000661	0.0039	CcSEcCtD
Dolutegravir—Insomnia—Captopril—systemic scleroderma	0.000659	0.00389	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000659	0.00389	CcSEcCtD
Dolutegravir—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000658	0.00388	CcSEcCtD
Dolutegravir—Abdominal pain—Mometasone—systemic scleroderma	0.000656	0.00387	CcSEcCtD
Dolutegravir—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000636	0.00376	CcSEcCtD
Dolutegravir—Mental disorder—Lisinopril—systemic scleroderma	0.000636	0.00376	CcSEcCtD
Dolutegravir—Dizziness—Pentoxifylline—systemic scleroderma	0.000636	0.00375	CcSEcCtD
Dolutegravir—Vertigo—Mycophenolic acid—systemic scleroderma	0.00063	0.00372	CcSEcCtD
Dolutegravir—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.000628	0.00371	CcSEcCtD
Dolutegravir—Fatigue—Captopril—systemic scleroderma	0.000628	0.00371	CcSEcCtD
Dolutegravir—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000624	0.00368	CcSEcCtD
Dolutegravir—Flatulence—Lisinopril—systemic scleroderma	0.000623	0.00368	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000622	0.00367	CcSEcCtD
Dolutegravir—Skin disorder—Azathioprine—systemic scleroderma	0.000617	0.00365	CcSEcCtD
Dolutegravir—Vomiting—Pentoxifylline—systemic scleroderma	0.000611	0.00361	CcSEcCtD
Dolutegravir—Rash—Pentoxifylline—systemic scleroderma	0.000606	0.00358	CcSEcCtD
Dolutegravir—Dermatitis—Pentoxifylline—systemic scleroderma	0.000605	0.00357	CcSEcCtD
Dolutegravir—Headache—Pentoxifylline—systemic scleroderma	0.000602	0.00355	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Captopril—systemic scleroderma	0.000596	0.00352	CcSEcCtD
Dolutegravir—Asthenia—Mometasone—systemic scleroderma	0.000595	0.00351	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000593	0.0035	CcSEcCtD
Dolutegravir—Nervous system disorder—Leflunomide—systemic scleroderma	0.000589	0.00348	CcSEcCtD
Dolutegravir—Pruritus—Mometasone—systemic scleroderma	0.000587	0.00346	CcSEcCtD
Dolutegravir—Skin disorder—Leflunomide—systemic scleroderma	0.000583	0.00344	CcSEcCtD
Dolutegravir—Abdominal pain—Captopril—systemic scleroderma	0.000576	0.0034	CcSEcCtD
Dolutegravir—Nausea—Pentoxifylline—systemic scleroderma	0.000571	0.00337	CcSEcCtD
Dolutegravir—Vertigo—Lisinopril—systemic scleroderma	0.000568	0.00335	CcSEcCtD
Dolutegravir—Diarrhoea—Mometasone—systemic scleroderma	0.000567	0.00335	CcSEcCtD
Dolutegravir—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000562	0.00332	CcSEcCtD
Dolutegravir—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000557	0.00329	CcSEcCtD
Dolutegravir—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000556	0.00328	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00055	0.00325	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000549	0.00324	CcSEcCtD
Dolutegravir—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000546	0.00322	CcSEcCtD
Dolutegravir—Insomnia—Leflunomide—systemic scleroderma	0.000543	0.00321	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000534	0.00316	CcSEcCtD
Dolutegravir—Vomiting—Mometasone—systemic scleroderma	0.000527	0.00311	CcSEcCtD
Dolutegravir—Rash—Mometasone—systemic scleroderma	0.000523	0.00309	CcSEcCtD
Dolutegravir—Asthenia—Captopril—systemic scleroderma	0.000523	0.00309	CcSEcCtD
Dolutegravir—Dermatitis—Mometasone—systemic scleroderma	0.000522	0.00308	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00052	0.00307	CcSEcCtD
Dolutegravir—Headache—Mometasone—systemic scleroderma	0.00052	0.00307	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000518	0.00306	CcSEcCtD
Dolutegravir—Insomnia—Mycophenolic acid—systemic scleroderma	0.000518	0.00306	CcSEcCtD
Dolutegravir—Fatigue—Leflunomide—systemic scleroderma	0.000518	0.00306	CcSEcCtD
Dolutegravir—Pruritus—Captopril—systemic scleroderma	0.000515	0.00304	CcSEcCtD
Dolutegravir—Neutropenia—Prednisone—systemic scleroderma	0.000504	0.00297	CcSEcCtD
Dolutegravir—Abdominal pain—Azathioprine—systemic scleroderma	0.000503	0.00297	CcSEcCtD
Dolutegravir—Skin disorder—Lisinopril—systemic scleroderma	0.000501	0.00296	CcSEcCtD
Dolutegravir—Diarrhoea—Captopril—systemic scleroderma	0.000498	0.00294	CcSEcCtD
Dolutegravir—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000498	0.00294	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000494	0.00292	CcSEcCtD
Dolutegravir—Fatigue—Mycophenolic acid—systemic scleroderma	0.000494	0.00292	CcSEcCtD
Dolutegravir—Nausea—Mometasone—systemic scleroderma	0.000493	0.00291	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000491	0.0029	CcSEcCtD
Dolutegravir—Hyperglycaemia—Prednisone—systemic scleroderma	0.000486	0.00287	CcSEcCtD
Dolutegravir—Dizziness—Captopril—systemic scleroderma	0.000482	0.00284	CcSEcCtD
Dolutegravir—Abdominal pain—Leflunomide—systemic scleroderma	0.000475	0.0028	CcSEcCtD
Dolutegravir—Hypersensitivity—Azathioprine—systemic scleroderma	0.000468	0.00277	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000468	0.00276	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000468	0.00276	CcSEcCtD
Dolutegravir—Insomnia—Lisinopril—systemic scleroderma	0.000467	0.00275	CcSEcCtD
Dolutegravir—Vomiting—Captopril—systemic scleroderma	0.000463	0.00273	CcSEcCtD
Dolutegravir—Rash—Captopril—systemic scleroderma	0.000459	0.00271	CcSEcCtD
Dolutegravir—Dermatitis—Captopril—systemic scleroderma	0.000459	0.00271	CcSEcCtD
Dolutegravir—Headache—Captopril—systemic scleroderma	0.000456	0.00269	CcSEcCtD
Dolutegravir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000453	0.00267	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000445	0.00263	CcSEcCtD
Dolutegravir—Fatigue—Lisinopril—systemic scleroderma	0.000445	0.00263	CcSEcCtD
Dolutegravir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000443	0.00262	CcSEcCtD
Dolutegravir—Hypersensitivity—Leflunomide—systemic scleroderma	0.000442	0.00261	CcSEcCtD
Dolutegravir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000439	0.00259	CcSEcCtD
Dolutegravir—Diarrhoea—Azathioprine—systemic scleroderma	0.000435	0.00257	CcSEcCtD
Dolutegravir—Nausea—Captopril—systemic scleroderma	0.000433	0.00255	CcSEcCtD
Dolutegravir—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000432	0.00255	CcSEcCtD
Dolutegravir—Asthenia—Leflunomide—systemic scleroderma	0.000431	0.00254	CcSEcCtD
Dolutegravir—Pruritus—Leflunomide—systemic scleroderma	0.000425	0.00251	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000422	0.00249	CcSEcCtD
Dolutegravir—Neutropenia—Methotrexate—systemic scleroderma	0.000421	0.00249	CcSEcCtD
Dolutegravir—Dizziness—Azathioprine—systemic scleroderma	0.00042	0.00248	CcSEcCtD
Dolutegravir—Asthenia—Mycophenolic acid—systemic scleroderma	0.000411	0.00243	CcSEcCtD
Dolutegravir—Diarrhoea—Leflunomide—systemic scleroderma	0.000411	0.00243	CcSEcCtD
Dolutegravir—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000409	0.00241	CcSEcCtD
Dolutegravir—Abdominal pain—Lisinopril—systemic scleroderma	0.000408	0.00241	CcSEcCtD
Dolutegravir—Pruritus—Mycophenolic acid—systemic scleroderma	0.000405	0.00239	CcSEcCtD
Dolutegravir—Vomiting—Azathioprine—systemic scleroderma	0.000404	0.00239	CcSEcCtD
Dolutegravir—Rash—Azathioprine—systemic scleroderma	0.000401	0.00237	CcSEcCtD
Dolutegravir—Dermatitis—Azathioprine—systemic scleroderma	0.0004	0.00236	CcSEcCtD
Dolutegravir—Headache—Azathioprine—systemic scleroderma	0.000398	0.00235	CcSEcCtD
Dolutegravir—Dizziness—Leflunomide—systemic scleroderma	0.000397	0.00234	CcSEcCtD
Dolutegravir—Renal failure—Methotrexate—systemic scleroderma	0.000395	0.00233	CcSEcCtD
Dolutegravir—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000392	0.00231	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00039	0.0023	CcSEcCtD
Dolutegravir—Immune system disorder—Prednisone—systemic scleroderma	0.000389	0.0023	CcSEcCtD
Dolutegravir—Vomiting—Leflunomide—systemic scleroderma	0.000382	0.00225	CcSEcCtD
Dolutegravir—Hypersensitivity—Lisinopril—systemic scleroderma	0.00038	0.00224	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00038	0.00224	CcSEcCtD
Dolutegravir—Dizziness—Mycophenolic acid—systemic scleroderma	0.000379	0.00224	CcSEcCtD
Dolutegravir—Rash—Leflunomide—systemic scleroderma	0.000379	0.00223	CcSEcCtD
Dolutegravir—Dermatitis—Leflunomide—systemic scleroderma	0.000378	0.00223	CcSEcCtD
Dolutegravir—Mental disorder—Prednisone—systemic scleroderma	0.000378	0.00223	CcSEcCtD
Dolutegravir—Nausea—Azathioprine—systemic scleroderma	0.000378	0.00223	CcSEcCtD
Dolutegravir—Headache—Leflunomide—systemic scleroderma	0.000376	0.00222	CcSEcCtD
Dolutegravir—Asthenia—Lisinopril—systemic scleroderma	0.00037	0.00219	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00218	CcSEcCtD
Dolutegravir—Pruritus—Lisinopril—systemic scleroderma	0.000365	0.00215	CcSEcCtD
Dolutegravir—Vomiting—Mycophenolic acid—systemic scleroderma	0.000364	0.00215	CcSEcCtD
Dolutegravir—Rash—Mycophenolic acid—systemic scleroderma	0.000361	0.00213	CcSEcCtD
Dolutegravir—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000361	0.00213	CcSEcCtD
Dolutegravir—Hepatitis—Methotrexate—systemic scleroderma	0.00036	0.00213	CcSEcCtD
Dolutegravir—Headache—Mycophenolic acid—systemic scleroderma	0.000359	0.00212	CcSEcCtD
Dolutegravir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000357	0.00211	CcSEcCtD
Dolutegravir—Nausea—Leflunomide—systemic scleroderma	0.000357	0.00211	CcSEcCtD
Dolutegravir—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000356	0.0021	CcSEcCtD
Dolutegravir—Urethral disorder—Methotrexate—systemic scleroderma	0.000353	0.00209	CcSEcCtD
Dolutegravir—Diarrhoea—Lisinopril—systemic scleroderma	0.000353	0.00208	CcSEcCtD
Dolutegravir—Dizziness—Lisinopril—systemic scleroderma	0.000341	0.00201	CcSEcCtD
Dolutegravir—Nausea—Mycophenolic acid—systemic scleroderma	0.00034	0.00201	CcSEcCtD
Dolutegravir—Vertigo—Prednisone—systemic scleroderma	0.000337	0.00199	CcSEcCtD
Dolutegravir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00197	CcSEcCtD
Dolutegravir—Vomiting—Lisinopril—systemic scleroderma	0.000328	0.00194	CcSEcCtD
Dolutegravir—Immune system disorder—Methotrexate—systemic scleroderma	0.000326	0.00192	CcSEcCtD
Dolutegravir—Rash—Lisinopril—systemic scleroderma	0.000325	0.00192	CcSEcCtD
Dolutegravir—Dermatitis—Lisinopril—systemic scleroderma	0.000325	0.00192	CcSEcCtD
Dolutegravir—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000324	0.00191	CcSEcCtD
Dolutegravir—Headache—Lisinopril—systemic scleroderma	0.000323	0.00191	CcSEcCtD
Dolutegravir—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00189	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000317	0.00187	CcSEcCtD
Dolutegravir—Mental disorder—Methotrexate—systemic scleroderma	0.000316	0.00186	CcSEcCtD
Dolutegravir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000309	0.00183	CcSEcCtD
Dolutegravir—Nausea—Lisinopril—systemic scleroderma	0.000306	0.00181	CcSEcCtD
Dolutegravir—Nervous system disorder—Prednisone—systemic scleroderma	0.0003	0.00177	CcSEcCtD
Dolutegravir—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000299	0.00176	CcSEcCtD
Dolutegravir—Skin disorder—Prednisone—systemic scleroderma	0.000298	0.00176	CcSEcCtD
Dolutegravir—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000287	0.0017	CcSEcCtD
Dolutegravir—Rash—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00168	CcSEcCtD
Dolutegravir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00168	CcSEcCtD
Dolutegravir—Headache—Mycophenolate mofetil—systemic scleroderma	0.000283	0.00167	CcSEcCtD
Dolutegravir—Vertigo—Methotrexate—systemic scleroderma	0.000282	0.00166	CcSEcCtD
Dolutegravir—Insomnia—Prednisone—systemic scleroderma	0.000277	0.00164	CcSEcCtD
Dolutegravir—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000268	0.00159	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000265	0.00157	CcSEcCtD
Dolutegravir—Fatigue—Prednisone—systemic scleroderma	0.000264	0.00156	CcSEcCtD
Dolutegravir—Nervous system disorder—Methotrexate—systemic scleroderma	0.000251	0.00148	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000251	0.00148	CcSEcCtD
Dolutegravir—Skin disorder—Methotrexate—systemic scleroderma	0.000249	0.00147	CcSEcCtD
Dolutegravir—Abdominal pain—Prednisone—systemic scleroderma	0.000242	0.00143	CcSEcCtD
Dolutegravir—Insomnia—Methotrexate—systemic scleroderma	0.000232	0.00137	CcSEcCtD
Dolutegravir—Hypersensitivity—Prednisone—systemic scleroderma	0.000226	0.00133	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000221	0.00131	CcSEcCtD
Dolutegravir—Fatigue—Methotrexate—systemic scleroderma	0.000221	0.0013	CcSEcCtD
Dolutegravir—Asthenia—Prednisone—systemic scleroderma	0.00022	0.0013	CcSEcCtD
Dolutegravir—Pruritus—Prednisone—systemic scleroderma	0.000217	0.00128	CcSEcCtD
Dolutegravir—Diarrhoea—Prednisone—systemic scleroderma	0.00021	0.00124	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000209	0.00124	CcSEcCtD
Dolutegravir—Dizziness—Prednisone—systemic scleroderma	0.000203	0.0012	CcSEcCtD
Dolutegravir—Abdominal pain—Methotrexate—systemic scleroderma	0.000202	0.0012	CcSEcCtD
Dolutegravir—Vomiting—Prednisone—systemic scleroderma	0.000195	0.00115	CcSEcCtD
Dolutegravir—Rash—Prednisone—systemic scleroderma	0.000193	0.00114	CcSEcCtD
Dolutegravir—Dermatitis—Prednisone—systemic scleroderma	0.000193	0.00114	CcSEcCtD
Dolutegravir—Headache—Prednisone—systemic scleroderma	0.000192	0.00113	CcSEcCtD
Dolutegravir—Hypersensitivity—Methotrexate—systemic scleroderma	0.000189	0.00111	CcSEcCtD
Dolutegravir—Asthenia—Methotrexate—systemic scleroderma	0.000184	0.00108	CcSEcCtD
Dolutegravir—Nausea—Prednisone—systemic scleroderma	0.000182	0.00107	CcSEcCtD
Dolutegravir—Pruritus—Methotrexate—systemic scleroderma	0.000181	0.00107	CcSEcCtD
Dolutegravir—Diarrhoea—Methotrexate—systemic scleroderma	0.000175	0.00103	CcSEcCtD
Dolutegravir—Dizziness—Methotrexate—systemic scleroderma	0.000169	0.001	CcSEcCtD
Dolutegravir—Vomiting—Methotrexate—systemic scleroderma	0.000163	0.000961	CcSEcCtD
Dolutegravir—Rash—Methotrexate—systemic scleroderma	0.000161	0.000953	CcSEcCtD
Dolutegravir—Dermatitis—Methotrexate—systemic scleroderma	0.000161	0.000952	CcSEcCtD
Dolutegravir—Headache—Methotrexate—systemic scleroderma	0.00016	0.000947	CcSEcCtD
Dolutegravir—Nausea—Methotrexate—systemic scleroderma	0.000152	0.000898	CcSEcCtD
